Skip to content
Delayed ~15 min

ALXO ALX ONCOLOGY HOLDINGS INC

Health Care · Russell 2000

Next earnings: not announced yet

What 9 analyst firms say about ALX ONCOLOGY HOLDINGS INC: their latest ratings, price targets and how far the stock is from them. How it works

1.16 USD+0.01 (+0.43%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+298.3%to the avg target 4.60 USD+3.45 USD
Buy 6 · Hold 2 · Sell 0

8 rated views · 9 analyst/firm records · 9 firms

Latest report17 Aug 2026avg report date 4 Jun
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
  • Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)

Recent analyst activity · last 90 days

Our tracked history has 3 reports on ALXO from 3 analyst firms in the last 90 days (9 firms in the past year).

Comparing each firm's latest target with its previous one: 2 left it unchanged.

No firm's latest available rating differs from its previous one.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Cantor FitzgeraldLi WatsekBuy15 Jun 2026—
H.C. WainwrightSwayampakula RamakanthBuy10 Aug 20264.00 USD
JefferiesRoger SongBuy1 Jul 20264.00 USD
Lifesci CapitalSam SlutskyHold2 Mar 2026—
Piper SandlerAllison M BratzelBuy17 Aug 20264.00 USD
UBSMichael J YeeBuy6 Mar 20266.00 USD
Weiss RatingsUnnamed analyst—17 Sep 2026—
Wells FargoDerek ArchilaBuy19 Mar 20265.00 USD
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 08:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.